Rituximab in Patients With Relapsed or Refractory TTP-HUS

Conditions

• Thrombotic Thrombocytopenic Purpura
• Hemolytic Uremic Syndrome

Interventions

• DRUG: Rituximab

Sponsor

Hamilton Health Sciences Corporation

Collaborators

• [object Object]
• [object Object]
• [object Object]